Find Clinical Drug Pipeline Developments & Deals for Senicapoc


All Data

Filters Filter refresh
Therapeutic Area filter
    Study Phase filter
      Country filter
        News Type filter
          Company filter

            Companies By Therapeutic Area Full Screen

            Development Status Full Screen

            Aarhus University

            • Development Update

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Senicapoc

            Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

            Highest Development Status: Phase II Product Type: Small molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable May 13, 2020


            The Danish government has given a grant to a research team at Aarhus University to launch a clinical trial which will investigate if the treatment can prevent the lung damage seen in COVID-19 and SARS, to reduce the need for a patient to be on a ventilator.